Escient Pharmaceuticals, targeted therapeutics for neurosensory-inflammatory disorders, $120M Series A with Abingworth, Forge Life Science Partners, New Enterprise Associates
Lipidio Pharmaceuticals, focuses on advancing a molecule to treat diseases associated with excess body fat, $20M Series A
Valcre, innovative appraisal platform for the commercial real estate industry, $12.7M Series A with Avenue Growth Partners
Personal AI, develops AI-based software to help users retain, reinforce, and recall human memory, $4.7M
KaiOS Technologies, powers an emerging global ecosystem of affordable digital products and services, $3.4M with Finnfund
Trio Pharmaceuticals, cancer therapeutics company that develops dual-action drugs for immunogenic tumors, $1.5M
MANSCAPED, global men’s lifestyle consumer brand, Series B with Banner Ventures, Smash Ventures